1. Others Vitamin D Related/Nuclear Receptor Metabolic Enzyme/Protease
  2. Isotope-Labeled Compounds Estrogen Receptor/ERR Endogenous Metabolite
  3. 2041095-50-3

2041095-50-3

Filgotinib-d<sub>4</sub> Chemical Structure

2041095-50-3

Chemical Structure

  • Filgotinib-d4
  • Synonym(s): GLPG0634-d4
  • CAS No: 2041095-50-3
    Formula: C21H19D4N5O3S
    Molecular Weight: 429.53
  • IUPAC Name: N-(5-(4-((1,1-dioxidothiomorpholino)methyl)phenyl)-[1,2,4]triazolo[1,5-a]pyridin-2-yl)cyclopropane-2,2,3,3-d4-1-carboxamide
  • InChIKey: RIJLVEAXPNLDTC-LZMSFWOYSA-N
  • SMILES: O=C(C1C([2H])([2H])C1([2H])[2H])NC2=NN3C(C4=CC=C(C=C4)CN5CCS(=O)(CC5)=O)=CC=CC3=N2

Biological Activity: Filgotinib-d4 is the deuterium labeled Filgotinib. Filgotinib (GLPG0634) is a selective JAK1 inhibitor with IC50 of 10 nM, 28 nM, 810 nM, and 116 nM for JAK1, JAK2, JAK3, and TYK2, respectively.

Cat. No. Product Name Purity Description
HY-18300S Filgotinib-d4 Filgotinib-d4 is the deuterium labeled Filgotinib. Filgotinib (GLPG0634) is a selective JAK1 inhibitor with IC50 of 10 nM, 28 nM, 810 nM, and 116 nM for JAK1, JAK2, JAK3, and TYK2, respectively.
HY-18300 Filgotinib 99.44% Filgotinib (GLPG0634) is a selective, orally available JAK1 inhibitor with anti-inflammatory and antiviral activities. Filgotinib can effectively inhibit the activities of JAK1, JAK2, JAK3 and TYK2 with IC50 values of 10 nM, 28 nM, 810 nM and 116 nM, respectively. Filgotinib also inhibits HIV-1 driven gene transcription and reduces proliferation of HIV-1 infected cells. Filgotinib can be used in the study of rheumatoid arthritis and inflammatory bowel disease.
HY-18300R Filgotinib (Standard) ≥98% Filgotinib (Standard) is the analytical standard of Filgotinib. This product is intended for research and analytical applications. Filgotinib (GLPG0634) is a selective and orally active JAK1 inhibitor with IC50 of 10 nM, 28 nM, 810 nM, and 116 nM for JAK1, JAK2, JAK3, and TYK2, respectively.